Form 4: Boston Scientific Executive Jeffrey Mirviss Reports Stock Transactions
SEC Form 4 Filing
EVP Jeffrey B. Mirviss of Boston Scientific reports the vesting of restricted stock units and associated tax withholding.
Summary
- On February 12, 2025, Jeffrey B. Mirviss, an EVP at Boston Scientific, reported transactions involving Boston Scientific common stock.
- Specifically, 2,115 restricted stock units vested, which were converted into common stock.
- Additionally, 868 shares were disposed of to cover tax obligations at a price of $105.77 per share.
- Following these transactions, Mirviss directly owns 29,701 shares of Boston Scientific common stock and 6,347 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to executive compensation. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Future Outlook
The remaining restricted stock units will vest in four equal annual installments beginning on February 12, 2025.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which investors often monitor for insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation adjustments.
Key Dates
| Date | Description |
|---|---|
| 02/12/2025 | Date of the reported transactions: vesting of restricted stock units and tax withholding. |
| 02/12/2025 | First vesting date of the remaining restricted stock units. |
| 02/14/2025 | Date of the form filing. |
| 02/12/2028 | Expiration date of the restricted stock units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.